Tel: +1-646-888-2339, Fax: +1-646-422-0492
NY-CO-58/KIF2C is overexpressed in a variety of solid tumors and induces frequent T cell responses in patients with colorectal cancer
Article first published online: 23 NOV 2009
Copyright © 2009 UICC
International Journal of Cancer
Volume 127, Issue 2, pages 381–393, 15 July 2010
How to Cite
Gnjatic, S., Cao, Y., Reichelt, U., Yekebas, E. F., Nölker, C., Marx, A. H., Erbersdobler, A., Nishikawa, H., Hildebrandt, Y., Bartels, K., Horn, C., Stahl, T., Gout, I., Filonenko, V., Ling, K.-L., Cerundolo, V., Luetkens, T., Ritter, G., Friedrichs, K., Leuwer, R., Hegewisch-Becker, S., Izbicki, J. R., Bokemeyer, C., Old, L. J. and Atanackovic, D. (2010), NY-CO-58/KIF2C is overexpressed in a variety of solid tumors and induces frequent T cell responses in patients with colorectal cancer. Int. J. Cancer, 127: 381–393. doi: 10.1002/ijc.25058
- Issue published online: 20 MAY 2010
- Article first published online: 23 NOV 2009
- Accepted manuscript online: 23 NOV 2009 12:00AM EST
- Manuscript Accepted: 20 OCT 2009
- Manuscript Received: 10 JUN 2009
- Deutsche Krebshilfe
- Erich und Gertrud Roggenbuck-Stiftung
- Eppendorfer Krebs- und Leukämiehilfe e.V.
- The Cancer Vaccine Collaborative (CVC)
- Cancer Research Institute
- The Harry Mahon Cancer Research Trust
Additional Supporting Information may be found in the online version of this article.
|IJC_25058_sm_SuppTable1.doc||33K||Supporting Information Table 1. Peptides from NY-CO-58 used in this study|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.